TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Kelyniam Global Secures Exclusive U.S. License for Evonik's VESTAKEEP® Fusion Biomaterial in Cranial Implants

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Desiree Webb
Kelyniam Global Secures Exclusive U.S. License for Evonik's VESTAKEEP® Fusion Biomaterial in Cranial Implants

Kelyniam Global has obtained an exclusive two-year U.S. license from Evonik Industries to market VESTAKEEP® Fusion, a bi-calcium phosphate-infused PEEK material for cranial and craniofacial implants, expanding its regenerative medicine portfolio.

Insights
KLYG   positive

Secured exclusive licensing deal, expanding product portfolio and potential market opportunities